Federico Grossi is Chief Medical Officer at Apellis Pharmaceuticals, Inc. (APLS). They have made 11 open-market trades across 1 company since 2020, most recently 2023-01-05.
CIK 0001720634
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APLS | 94,884 | $3.9M |
Shares reported on the most recent Form 4, priced at the 2023-01-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APLS | SELL | 2023-01-05 | 2023-01-09 | $48.79 | $122K | +9.1% | +9.6% | +65.3% |
| APLS | SELL | 2022-12-01 | 2022-12-02 | $49.93 | $125K | +4.6% | -0.2% | +27.8% |
| APLS | SELL | 2022-11-01 | 2022-11-03 | $60.83 | $152K | -6.8% | -1.2% | +10.1% |
| APLS | SELL | 2022-10-03 | 2022-10-05 | $66.69 | $167K | +2.1% | -11.8% | -12.1% |
| APLS | SELL | 2022-09-01 | 2022-09-02 | $60.30 | $151K | +7.2% | +1.1% | -17.6% |
| APLS | SELL | 2022-08-01 | 2022-08-02 | $55.99 | $140K | +21.3% | +13.5% | +8.0% |
| APLS | SELL | 2022-06-01 | 2022-06-02 | $41.78 | $104K | -7.5% | +14.3% | +44.0% |
| APLS | SELL | 2022-05-02 | 2022-05-03 | $43.56 | $109K | -11.6% | -4.6% | +25.0% |
| APLS | SELL · 10b5-1 | 2022-03-15 | 2022-03-17 | $39.57 | $15K | +4.0% | +9.8% | -12.1% |
| APLS | SELL · 10b5-1 | 2022-03-01 | 2022-03-02 | $43.53 | $16K | -13.9% | +20.0% | -9.5% |
| APLS | SELL · 10b5-1 | 2022-02-15 | 2022-02-16 | $45.43 | $17K | -2.6% | +15.2% | -8.2% |
| APLS | SELL · 10b5-1 | 2022-02-01 | 2022-02-02 | $40.58 | $15K | +12.6% | +9.0% | +11.7% |
| APLS | SELL · 10b5-1 | 2022-01-14 | 2022-01-19 | $40.56 | $15K | +6.0% | +12.4% | +37.5% |
| APLS | SELL · 10b5-1 | 2022-01-03 | 2022-01-04 | $47.31 | $18K | -14.1% | -14.3% | +24.1% |
| APLS | SELL · 10b5-1 | 2021-12-15 | 2021-12-17 | $42.88 | $16K | +3.7% | -16.9% | +1.3% |
| APLS | SELL · 10b5-1 | 2021-12-01 | 2021-12-03 | $42.40 | $16K | +6.7% | +17.4% | +6.4% |
| APLS | SELL · 10b5-1 | 2021-11-15 | 2021-11-17 | $43.50 | $27K | -6.3% | +5.0% | +4.8% |
| APLS | SELL · 10b5-1 | 2021-11-01 | 2021-11-02 | $30.70 | $19K | +32.7% | +33.3% | +22.8% |
| APLS | SELL · 10b5-1 | 2021-10-14 | 2021-10-15 | $34.57 | $26K | -7.8% | +24.6% | +20.8% |
| APLS | SELL · 10b5-1 | 2021-10-01 | 2021-10-05 | $33.26 | $25K | +4.8% | +4.1% | +47.7% |
| APLS | SELL · 10b5-1 | 2021-08-02 | 2021-08-03 | $63.99 | $16K | -8.7% | -0.5% | -48.4% |
| APLS | SELL · 10b5-1 | 2021-07-14 | 2021-07-15 | $64.68 | $32K | +3.8% | -11.1% | -46.3% |
| APLS | SELL · 10b5-1 | 2021-07-08 | 2021-07-09 | $65.68 | $16K | -0.7% | -7.4% | -49.9% |
| APLS | SELL · 10b5-1 | 2021-06-14 | 2021-06-15 | $61.84 | $31K | +5.5% | +4.8% | -46.1% |
| APLS | SELL · 10b5-1 | 2021-05-14 | 2021-05-18 | $45.39 | $23K | +12.3% | +19.3% | +12.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.